All In Biotech

Drug Trial Radar · NCT05564377

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Molecular Analysis for Combination Therapy Choice (ComboMATCH)

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 2,900 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

2,900

Planned (sponsor's estimate)

Start

Apr 7, 2023

Primary completion

Jul 1, 2030

Study completion Jul 1, 2030

Sponsor

Sponsor type
NIH
First posted
Oct 3, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Screening
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.

Conditions

  • Advanced Malignant Solid Neoplasm
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Locally Advanced Malignant Solid Neoplasm
  • Malignant Female Reproductive System Neoplasm
  • Metastatic HER2-Negative Breast Carcinoma
  • Metastatic Malignant Solid Neoplasm
  • Recurrent Endometrial Carcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Malignant Female Reproductive System Neoplasm
  • Recurrent Malignant Solid Neoplasm
  • Recurrent Ovarian Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
  • Unresectable HER2-Negative Breast Carcinoma
  • Unresectable Malignant Solid Neoplasm

Interventions

  • AlpelisibDrug

    Given PO

  • BinimetinibDrug

    Given PO

  • Biopsy ProcedureProcedure

    Undergo biopsy

  • Biospecimen CollectionProcedure

    Undergo blood collection

  • Bone Marrow AspirationProcedure

    Undergo bone marrow aspiration

  • Bone Marrow BiopsyProcedure

    Undergo bone marrow biopsy

  • Bone ScanProcedure

    Undergo bone scan

  • Computed TomographyProcedure

    Undergo CT

  • Echocardiography TestProcedure

    Undergo ECHO

  • FluorouracilDrug

    Given IV

  • FulvestrantDrug

    Given IM

  • IpatasertibDrug

    Given PO

  • LeucovorinDrug

    Given IV

  • Magnetic Resonance ImagingProcedure

    Undergo MRI

  • Multigated Acquisition ScanProcedure

    Undergo MUGA

  • Mutation Carrier ScreeningProcedure

    Undergo tumor mutational screening

  • Neratinib MaleateDrug

    Given PO

  • Nilotinib Hydrochloride MonohydrateDrug

    Given PO

  • OlaparibDrug

    Given PO

  • OxaliplatinDrug

    Given IV

  • PaclitaxelDrug

    Given PO or IV

  • PalbociclibDrug

    Given PO

  • PanitumumabBiological

    Given IV

  • Positron Emission TomographyProcedure

    Undergo PET

  • Selumetinib SulfateDrug

    Given PO

  • SotorasibDrug

    Given PO

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Accrual of patients to ComboMATCH treatment trialsTime frame: Up to 8 years
  2. Assignment of patients to ComboMATCH treatment trialsTime frame: Up to 8 years
  3. Enrollment rates to ComboMATCH treatment trialsTime frame: Up to 8 years

Locations

484 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama · Recruiting

  • University of South Alabama Mitchell Cancer Institute

    Mobile, Alabama · Recruiting

  • Alaska Women's Cancer Care

    Anchorage, Alaska · Recruiting

  • CTCA at Western Regional Medical Center

    Goodyear, Arizona · Recruiting

  • Kingman Regional Medical Center

    Kingman, Arizona · Recruiting

  • Mayo Clinic Hospital in Arizona

    Phoenix, Arizona · Suspended

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro

    Jonesboro, Arkansas · Recruiting

  • PCR Oncology

    Arroyo Grande, California · Recruiting

  • Mercy Cancer Center - Carmichael

    Carmichael, California · Recruiting

  • Mercy San Juan Medical Center

    Carmichael, California · Recruiting

  • Epic Care-Dublin

    Dublin, California · Active not recruiting

  • Mercy Cancer Center - Elk Grove

    Elk Grove, California · Recruiting

  • UC San Diego Health System - Encinitas

    Encinitas, California · Recruiting

  • UC San Diego Moores Cancer Center

    La Jolla, California · Recruiting

  • The Angeles Clinic and Research Institute - West Los Angeles Office

    Los Angeles, California · Recruiting

  • Cedars-Sinai Medical Center

    Los Angeles, California · Recruiting

  • Contra Costa Regional Medical Center

    Martinez, California · Active not recruiting

  • Children's Hospital of Orange County

    Orange, California · Recruiting

  • Saint Joseph Hospital - Orange

    Orange, California · Recruiting

  • Stanford Cancer Institute Palo Alto

    Palo Alto, California · Recruiting

  • VA Palo Alto Health Care System

    Palo Alto, California · Recruiting

  • Mercy Cancer Center - Rocklin

    Rocklin, California · Recruiting

  • Mercy Cancer Center - Sacramento

    Sacramento, California · Recruiting

  • UC San Diego Medical Center - Hillcrest

    San Diego, California · Recruiting

  • Sharp Memorial Hospital

    San Diego, California · Recruiting

  • UCSF Medical Center-Mission Bay

    San Francisco, California · Suspended

  • Saint John's Cancer Institute

    Santa Monica, California · Recruiting

  • Epic Care Cyberknife Center

    Walnut Creek, California · Active not recruiting

  • Presbyterian Intercommunity Hospital

    Whittier, California · Suspended

  • Woodland Memorial Hospital

    Woodland, California · Recruiting

  • UCHealth University of Colorado Hospital

    Aurora, Colorado · Recruiting

  • Poudre Valley Hospital

    Fort Collins, Colorado · Recruiting

  • Cancer Care and Hematology-Fort Collins

    Fort Collins, Colorado · Recruiting

  • UCHealth Greeley Hospital

    Greeley, Colorado · Recruiting

  • Medical Center of the Rockies

    Loveland, Colorado · Recruiting

  • Helen F Graham Cancer Center

    Newark, Delaware · Recruiting

  • Medical Oncology Hematology Consultants PA

    Newark, Delaware · Recruiting

  • UM Sylvester Comprehensive Cancer Center at Aventura

    Aventura, Florida · Recruiting

  • UM Sylvester Comprehensive Cancer Center at Coral Gables

    Coral Gables, Florida · Recruiting

  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach

    Deerfield Beach, Florida · Recruiting

Showing 40 of 484 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.